Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

AVEO Pharmaceuticals Revenue 2009-2018 | AVEO

AVEO Pharmaceuticals revenue from 2009 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
AVEO Pharmaceuticals Annual Revenue
(Millions of US $)
2017 $8
2016 $3
2015 $19
2014 $18
2013 $1
2012 $19
2011 $165
2010 $45
2009 $21
2008 $20
AVEO Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q3 2018 $2
Q2 2018 $0
Q1 2018 $1
Q4 2017 $0
Q3 2017 $5
Q2 2017 $0
Q1 2017 $3
Q4 2016 $0
Q3 2016 $1
Q2 2016 $0
Q1 2016 $1
Q4 2015 $4
Q3 2015 $15
Q2 2015 $0
Q1 2015 $0
Q4 2014 $0
Q3 2014 $1
Q2 2014 $2
Q1 2014 $15
Q4 2013 $0
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Q4 2012 $16
Q3 2012 $1
Q2 2012 $2
Q1 2012 $1
Q4 2011 $1
Q3 2011 $4
Q2 2011 $27
Q1 2011 $134
Q4 2010 $12
Q3 2010 $6
Q2 2010 $16
Q1 2010 $11
Q4 2009 $6
Q3 2009 $6
Q2 2009 $5
Q1 2009 $4
Q4 2008 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.077B $0.008B
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing novel cancer therapeutics. Its product candidates are targeted against important mechanisms known or believed to be involved in cancer. Tivozanib, the Company's lead product candidate, is a highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2 and 3. In addition to tivozanib, AVEO Pharmaceuticals has a pipeline of monoclonal antibodies derived from Human Response Platform (HRP), a novel method of building preclinical models of human cancer, which are intended to more accurately represent cancer biology in patients. AV-299 is the Company's next product candidate which is an antibody that binds to hepatocyte growth factor, or HGF, thereby blocking its function. AVEO Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.200B 13.07
Gilead Sciences (GILD) United States $87.436B 10.97
Biogen (BIIB) United States $65.479B 12.69
Celgene (CELG) United States $63.576B 11.78
Vertex Pharmaceuticals (VRTX) United States $48.081B 64.41
Regeneron Pharmaceuticals (REGN) United States $46.330B 21.52
Illumina (ILMN) United States $44.074B 52.42
Alexion Pharmaceuticals (ALXN) United States $28.921B 17.93
Incyte (INCY) United States $17.908B 168.30
BioMarin Pharmaceutical (BMRN) United States $16.736B 0.00
Seattle Genetics (SGEN) United States $11.477B 0.00
Exact Sciences (EXAS) United States $10.883B 0.00
Sarepta Therapeutics (SRPT) United States $9.252B 0.00
QIAGEN (QGEN) Netherlands $8.819B 28.84
Alnylam Pharmaceuticals (ALNY) United States $8.451B 0.00
BeiGene (BGNE) Cayman Islands $7.856B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.748B 49.54
Bluebird Bio (BLUE) United States $7.495B 0.00
Bio-Techne Corp (TECH) United States $7.237B 48.76
Moderna (MRNA) United States $7.053B 0.00
Exelixis (EXEL) United States $6.655B 15.57
Amarin (AMRN) Ireland $5.703B 0.00
Galapagos (GLPG) Belgium $5.283B 0.00
Alkermes (ALKS) Ireland $5.056B 0.00
Array BioPharma (ARRY) United States $5.047B 0.00
Guardant Health (GH) United States $4.379B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.077B 0.00
Horizon Pharma Public (HZNP) Ireland $3.884B 15.98
Allogene Therapeutics (ALLO) United States $3.795B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.458B 0.00
Emergent Biosolutions (EBS) United States $3.371B 28.39
Blueprint Medicines (BPMC) United States $3.339B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.286B 0.00
Ascendis Pharma (ASND) Denmark $3.087B 0.00
Genomic Health (GHDX) United States $3.010B 101.63
ACADIA Pharmaceuticals (ACAD) United States $2.908B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.865B 0.00
Global Blood Therapeutics (GBT) United States $2.722B 0.00
Immunomedics (IMMU) United States $2.710B 0.00
China Biologic Products (CBPO) China $2.701B 19.23
Repligen (RGEN) United States $2.640B 82.45
Ligand Pharmaceuticals (LGND) United States $2.569B 18.45
Reata Pharmaceuticals (RETA) United States $2.566B 0.00
Mirati Therapeutics (MRTX) United States $2.496B 0.00
Akcea Therapeutics (AKCA) United States $2.472B 0.00
Arena Pharmaceuticals (ARNA) United States $2.466B 0.00
Halozyme Therapeutics (HALO) United States $2.463B 54.97
Myriad Genetics (MYGN) United States $2.305B 23.48
Amicus Therapeutics (FOLD) United States $2.162B 0.00
Insmed (INSM) United States $2.087B 0.00
Spark Therapeutics (ONCE) United States $1.992B 0.00
Denali Therapeutics (DNLI) United States $1.991B 0.00
Acceleron Pharma (XLRN) United States $1.961B 0.00
Atara Biotherapeutics (ATRA) United States $1.846B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.830B 0.00
Medicines (MDCO) United States $1.830B 0.00
AnaptysBio (ANAB) United States $1.829B 0.00
REGENXBIO (RGNX) United States $1.725B 23.14
MyoKardia (MYOK) United States $1.719B 0.00
NeoGenomics (NEO) United States $1.649B 135.69
CRISPR Therapeutics AG (CRSP) Switzerland $1.636B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.630B 0.00
Myovant Sciences (MYOV) United Kingdom $1.509B 0.00
Innoviva (INVA) United States $1.497B 4.13
Allakos (ALLK) United States $1.468B 0.00
Aimmune Therapeutics (AIMT) United States $1.422B 0.00
UniQure (QURE) Netherlands $1.396B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.380B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.347B 0.00
Clovis Oncology (CLVS) United States $1.344B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.282B 0.00
Lion Biotechnologies (IOVA) United States $1.272B 0.00
Cambrex (CBM) United States $1.265B 13.65
Codexis (CDXS) United States $1.184B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.172B 0.00
WAVE Life Sciences (WVE) Singapore $1.108B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.107B 44.91
Rubius Therapeutics (RUBY) United States $1.104B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.092B 0.00
Audentes Therapeutics (BOLD) United States $1.055B 0.00
Puma Biotechnology (PBYI) United States $1.055B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.034B 0.00
Epizyme (EPZM) United States $1.020B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.978B 0.00
Editas Medicine (EDIT) United States $0.960B 0.00
Fate Therapeutics (FATE) United States $0.960B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.958B 0.00
Coherus BioSciences (CHRS) United States $0.948B 0.00
Sangamo Therapeutics (SGMO) United States $0.897B 0.00
Retrophin (RTRX) United States $0.889B 0.00
Athenex (ATNX) United States $0.846B 0.00
Vericel (VCEL) United States $0.845B 0.00
CytomX Therapeutics (CTMX) United States $0.829B 0.00
Novavax (NVAX) United States $0.815B 0.00
G1 THERAPEUTICS (GTHX) United States $0.781B 0.00
Apellis Pharmaceuticals (APLS) United States $0.778B 0.00
InflaRx (IFRX) Germany $0.777B 0.00
Arvinas (ARVN) United States $0.770B 0.00
Intra-Cellular Therapies (ITCI) United States $0.765B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.761B 0.00
Heska (HSKA) United States $0.743B 60.84
Cellectis (CLLS) France $0.726B 0.00
Principia Biopharma (PRNB) United States $0.723B 0.00
ANI Pharmaceuticals (ANIP) United States $0.722B 13.81
Dicerna Pharmaceuticals (DRNA) United States $0.718B 0.00
Dynavax Technologies (DVAX) United States $0.698B 0.00
Acorda Therapeutics (ACOR) United States $0.680B 8.83
Cara Therapeutics (CARA) United States $0.670B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.662B 0.00
Revance Therapeutics (RVNC) United States $0.654B 0.00
RA PHARMCTL INC (RARX) United States $0.650B 0.00
Viking Therapeutics (VKTX) United States $0.648B 0.00
Twist Bioscience (TWST) United States $0.643B 0.00
Intellia Therapeutics (NTLA) United States $0.607B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.577B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.567B 0.00
UROGEN PHARMA (URGN) Israel $0.565B 0.00
Kura Oncology (KURA) United States $0.564B 0.00
Eidos Therapeutics (EIDX) United States $0.563B 0.00
Anika Therapeutics (ANIK) United States $0.562B 23.25
Osiris Therapeutics (OSIR) United States $0.550B 0.00
Synthorx (THOR) United States $0.546B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.542B 0.00
Arcus Biosciences (RCUS) United States $0.529B 0.00
Prothena (PRTA) Ireland $0.524B 0.00
Zymeworks (ZYME) Canada $0.502B 0.00
PDL BioPharma (PDLI) United States $0.486B 7.93
UNITY Biotechnology (UBX) $0.476B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.466B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.465B 0.00
Scholar Rock Holding (SRRK) United States $0.462B 0.00
ObsEva SA (OBSV) Switzerland $0.451B 0.00
DBV Technologies (DBVT) France $0.450B 0.00
Zealand Pharma (ZEAL) Denmark $0.450B 4.96
Senesco Technologies (ELOX) United States $0.446B 0.00
Replimune (REPL) United States $0.444B 0.00
Agenus (AGEN) United States $0.433B 0.00
Cytokineticsorporated (CYTK) United States $0.432B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.424B 0.00
Kezar Life Sciences (KZR) United States $0.420B 0.00
Five Prime Therapeutics (FPRX) United States $0.411B 0.00
OSMOTICA PHARM (OSMT) United States $0.406B 0.00
BeyondSpring (BYSI) United States $0.404B 0.00
Mesoblast (MESO) Australia $0.398B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.373B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.369B 0.00
Kindred Biosciences (KIN) United States $0.367B 0.00
Sinovac Biotech (SVA) China $0.367B 0.00
AVROBIO (AVRO) United States $0.367B 0.00
Stemline Therapeutics (STML) United States $0.365B 0.00
Cellular Biomedicine (CBMG) United States $0.360B 0.00
Inovio Pharmaceuticals (INO) United States $0.353B 0.00
MeiraGTx Holdings (MGTX) United States $0.350B 0.00
Gamida Cell (GMDA) Israel $0.339B 0.00
Gritstone Oncology (GRTS) United States $0.337B 0.00
Krystal Biotech (KRYS) United States $0.332B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.330B 0.00
BioDelivery Sciences (BDSI) United States $0.328B 0.00
MediciNova (MNOV) United States $0.322B 0.00
Aduro Biotech (ADRO) United States $0.322B 0.00
Abeona Therapeutics (ABEO) United States $0.318B 0.00
Albireo Pharma (ALBO) United States $0.316B 0.00
Urovant Sciences (UROV) United States $0.314B 0.00
XBiotech (XBIT) United States $0.310B 0.00
Constellation Pharmaceuticals (CNST) United States $0.308B 0.00
Magenta Therapeutics (MGTA) United States $0.306B 0.00
Evelo Biosciences (EVLO) United States $0.292B 0.00
Enochian BioSciences (ENOB) United States $0.287B 0.00
Sorrento Therapeutics (SRNE) United States $0.285B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.283B 0.00
Solid Biosciences (SLDB) United States $0.283B 0.00
Axsome Therapeutics (AXSM) United States $0.278B 0.00
Geron (GERN) United States $0.274B 0.00
Intec Pharma (NTEC) Israel $0.269B 0.00
AC Immune SA (ACIU) Switzerland $0.261B 0.00
Kadmon Holdings (KDMN) United States $0.259B 0.00
Merus (MRUS) Netherlands $0.258B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.254B 0.00
Kodiak Sciences (KOD) United States $0.252B 0.00
Seres Therapeutics (MCRB) United States $0.250B 0.00
Liquidia Technologies (LQDA) United States $0.247B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.247B 0.00
Kala Pharmaceuticals (KALA) United States $0.244B 0.00
Verastem (VSTM) United States $0.244B 0.00
Celcuity (CELC) United States $0.241B 0.00
Adverum Biotechnologies (ADVM) United States $0.240B 0.00
Synlogic (SYBX) United States $0.236B 0.00
Kamada (KMDA) Israel $0.236B 10.64
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
MannKind (MNKD) United States $0.231B 0.00
Syros Pharmaceuticals (SYRS) United States $0.231B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.229B 0.00
Sutro Biopharma (STRO) United States $0.225B 0.00
ResTORbio (TORC) United States $0.225B 0.00
Strongbridge Biopharma (SBBP) United States $0.221B 0.00
TOCAGEN INC (TOCA) United States $0.219B 0.00
Athersys (ATHX) United States $0.217B 0.00
Arbutus Biopharma (ABUS) Canada $0.215B 0.00
LogicBio Therapeutics (LOGC) United States $0.209B 0.00
ChromaDex (CDXC) United States $0.208B 0.00
Cerecor (CERC) United States $0.207B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.204B 0.00
Celyad SA (CYAD) Belgium $0.201B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.200B 0.00
ADMA Biologics Inc (ADMA) United States $0.196B 0.00
Aptinyx (APTX) United States $0.189B 0.00
Compugen (CGEN) Israel $0.186B 0.00
Spero Therapeutics (SPRO) United States $0.182B 0.00
CorMedix Inc (CRMD) United States $0.178B 0.00
Protagonist Therapeutics (PTGX) United States $0.178B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.174B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.166B 0.00
Enzo Biochem (ENZ) United States $0.166B 0.00
Menlo Therapeutics (MNLO) United States $0.164B 0.00
Palatin Technologies (PTN) United States $0.160B 78.98
Syndax Pharmaceuticals (SNDX) United States $0.159B 0.00
VBI Vaccines (VBIV) United States $0.157B 0.00
Mersana Therapeutics (MRSN) United States $0.156B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.155B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.151B 0.00
Proteostasis Therapeutics (PTI) United States $0.149B 0.00
BioTime (BTX) United States $0.149B 0.00
OvaScience (MLND) United States $0.145B 0.00
Allena Pharmaceuticals (ALNA) United States $0.143B 0.00
Cohbar (CWBR) United States $0.137B 0.00
BioXcel Therapeutics (BTAI) United States $0.136B 0.00
Cue Biopharma (CUE) United States $0.134B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.133B 0.00
Unum Therapeutics (UMRX) United States $0.129B 0.00
Organovo Holdings (ONVO) United States $0.128B 0.00
Pfenex (PFNX) United States $0.127B 0.00
Trevena (TRVN) United States $0.127B 0.00
Fortress Biotech (FBIO) United States $0.124B 0.00
Mustang Bio (MBIO) United States $0.122B 0.00
Anavex Life Sciences (AVXL) United States $0.121B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.121B 0.00
Checkpoint Therapeutics (CKPT) United States $0.121B 0.00
Pluristem Therapeutics (PSTI) Israel $0.119B 0.00
Eton Pharmaceuticals (ETON) United States $0.119B 0.00
XOMA (XOMA) United States $0.118B 0.00
Equillium (EQ) United States $0.113B 0.00
Oncobiologics (OTLK) United States $0.112B 0.00
Catalyst Biosciences (CBIO) United States $0.107B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
VolitionRX (VNRX) Singapore $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
VTv Therapeutics (VTVT) United States $0.097B 0.00
Chiasma (CHMA) United States $0.095B 0.00
Neothetics (EVFM) United States $0.093B 0.00
Signal Genetics (MGEN) United States $0.091B 0.00
NantKwest (NK) United States $0.090B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.082B 0.00
Cel-Sci (CVM) United States $0.081B 0.00
Cocrystal Pharma (COCP) United States $0.079B 88.33
Merrimack Pharmaceuticals (MACK) United States $0.078B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.078B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.078B 0.00
Orgenesis (ORGS) United States $0.077B 0.00
Alimera Sciences (ALIM) United States $0.076B 0.00
Provention Bio (PRVB) United States $0.075B 0.00
PHASEBIO PHARMA (PHAS) United States $0.073B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Aptose Biosciences (APTO) Canada $0.072B 0.00
Cidara Therapeutics (CDTX) United States $0.070B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Celldex Therapeutics (CLDX) United States $0.067B 0.00
Protalix BioTherapeutics (PLX) Israel $0.067B 0.00
SESEN BIO, INC (SESN) United States $0.065B 0.00
AEterna Zentaris (AEZS) United States $0.065B 12.28
Sienna Biopharmaceuticals (SNNA) United States $0.062B 0.00
OVID THERAPEUTC (OVID) United States $0.062B 0.00
Prima BioMed (IMMP) Australia $0.060B 0.00
Applied Genetic Technologies (AGTC) United States $0.059B 0.00
Evogene (EVGN) Israel $0.058B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.058B 0.00
Ophthotech (OPHT) United States $0.058B 0.00
Proteon Therapeutics (PRTO) United States $0.057B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Vaccinex (VCNX) United States $0.056B 0.00
Eyenovia (EYEN) United States $0.056B 0.00
Entera Bio (ENTX) Israel $0.054B 0.00
VIVUS (VVUS) United States $0.054B 0.00
ScPharmaceuticals (SCPH) United States $0.053B 0.00
ARAVIVE, INC (ARAV) United States $0.053B 4.67
Alcobra (ARCT) United States $0.053B 0.00
Clearside Biomedical (CLSD) United States $0.051B 0.00
Asterias Biotherapeutics (AST) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Bellerophon Therapeutics (BLPH) United States $0.048B 0.00
VistaGen Therapeutics (VTGN) United States $0.045B 0.00
Selecta Biosciences (SELB) United States $0.044B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
Celsion (CLSN) United States $0.041B 0.00
Caladrius Biosciences (CLBS) United States $0.041B 0.00
OncoSec Medical (ONCS) United States $0.041B 0.00
Moleculin Biotech (MBRX) United States $0.040B 0.00
Motif Bio Plc (MTFB) United States $0.040B 0.00
Arsanis (ASNS) United States $0.039B 0.00
DiaMedica Therapeutics (DMAC) United States $0.038B 0.00
AquaBounty Technologies (AQB) United States $0.038B 0.00
Aptevo Therapeutics (APVO) United States $0.037B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.034B 5.58
Curis (CRIS) United States $0.034B 0.00
Sophiris Bio (SPHS) United States $0.033B 0.00
Galena Biopharma (SLS) United States $0.031B 0.00
AZURRX BIOPHARM (AZRX) United States $0.031B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.031B 0.00
Adial Pharmaceuticals (ADIL) United States $0.030B 0.00
TRACON Pharmaceuticals (TCON) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.028B 0.00
IMMURON LTD (IMRN) Australia $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
Oragenics (OGEN) United States $0.028B 0.00
Advaxis (ADXS) United States $0.028B 0.00
Zosano Pharma (ZSAN) United States $0.026B 0.00
Novelion Therapeutics (NVLN) Canada $0.025B 0.00
GENPREX INC (GNPX) United States $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
GTx (GTXI) United States $0.023B 0.00
Vical (VICL) United States $0.022B 0.00
BioPharmX (BPMX) United States $0.021B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.021B 0.00
CytRx (CYTR) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.020B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
IBio (IBIO) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
ATyr Pharma (LIFE) United States $0.015B 0.00
Soligenix (SNGX) United States $0.015B 0.00
Therapix Biosciences (TRPX) Israel $0.014B 7.25
Prana Biotechnology (PRAN) Australia $0.014B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Aytu Bioscience (AYTU) United States $0.013B 0.00
Edge Therapeutics (EDGE) United States $0.013B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Neuralstem (CUR) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.008B 0.00
RestorGenex (DFFN) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
Histogenics (HSGX) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00